Back to homepage

Tag "Type 2 diabetes"

Diabetes: how to manage cardiovascular risk in secondary prevention patients

Authors: Sarah L Anderson, Joel C Marrs

This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.


Diabetes: how to manage chronic kidney disease

Authors: Jennifer N Clements

This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.


Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions

Authors: Sarah L Anderson, Matteo Bassetti, Arduino A Mangoni

The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.


Management of type 2 diabetes: consensus of diabetes organizations

Authors: Elaena Quattrocchi BS, PharmD, FASHP, CDE, Tamara Goldberg BS, PharmD, BCPS, Nino Marzella BS, MS, PharmD

This article reviews the recommendations of different diabetes organizations for achieving glycemic control.


Clinical potential of treatment with semaglutide in type 2 diabetes patients

Authors: Michael E Røder

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2